A deep sternal wound infection caused by Ureaplasma urealyticum

References

1. Bosshard, P. P., Kronenberg, A., Zbinden, R., Ruef, C., Bottger, E. C. & Altwegg, M. ( 2003; ). Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. Clin Infect Dis 37, 167–172.[CrossRef]
   [Google Scholar]
2. Cordtz, J. & Jensen, J. S. ( 2006; ). Disseminated Ureaplasma urealyticum infection in a hypo-gammaglobulinaemic renal transplant patient. Scand J Infect Dis 38, 1114–1117.[CrossRef]
   [Google Scholar]
3. Garcia-de-la-Fuente, C., Minambres, E., Ugalde, E., Saez, A., Martinez-Martinez, L. & Farinas, M. C. ( 2008; ). Post-operative mediastinitis, pleuritis and pericarditis due to Mycoplasma hominis and Ureaplasma urealyticum with a fatal outcome. J Med Microbiol 57, 656–657.[CrossRef]
   [Google Scholar]
4. Geissdorfer, W., Sandner, G., John, S., Gessner, A., Schoerner, C. & Schroppel, K. ( 2008; ). Ureaplasma urealyticum meningitis in an adult patient. J Clin Microbiol 46, 1141–1143.[CrossRef]
   [Google Scholar]
5. Kenny, G. E. & Cartwright, F. D. ( 2001; ). Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob Agents Chemother 45, 2604–2608.[CrossRef]
   [Google Scholar]
6. Krausse, R. & Schubert, S. ( 2010; ). In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect 16, (in press).
   [Google Scholar]
7. Mauermann, W. J., Sampathkumar, P. & Thompson, R. L. ( 2008; ). Sternal wound infections. Best Pract Res Clin Anaesthesiol 22, 423–436.[CrossRef]
   [Google Scholar]
8. Pereyre, S., Gonzalez, P., de Barbeyrac, B., Darnige, A., Renaudin, H., Charron, A., Raherison, S., Bebear, C. & Bebear, C. M. ( 2002; ). Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis. Antimicrob Agents Chemother 46, 3142–3150.[CrossRef]
   [Google Scholar]
9. Pigrau, C., Almirante, B., Gasser, I. & Pahissa, A. ( 1995; ). Sternotomy infection due to Mycoplasma hominis and Ureaplasma urealyticum. Eur J Clin Microbiol Infect Dis 14, 597–598.[CrossRef]
   [Google Scholar]
10. Robertson, J. A., Stemke, G. W., Davis, J. W., Jr, Harasawa, R., Thirkell, D., Kong, F., Shepard, M. C. & Ford, D. K. ( 2002; ). Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001. Int J Syst Evol Microbiol 52, 587–597.
    [Google Scholar]
11. Waites, K. B. & Taylor-Robinson, D. ( 2007; ). Mycoplasma and ureaplasma. In Manual of Clinical Microbiology, 9th edn, pp. 1004–1020. Edited by Murray, P. R., Baron, E. J., Jorgensen, J. H., Landry, M. L. & Pfaller, M. A.. Washington, DC. : American Society for Microbiology.
    [Google Scholar]
12. Waites, K. B., Katz, B. & Schelonka, R. L. ( 2005; ). Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev 18, 757–789.[CrossRef]
    [Google Scholar]
13. Walkty, A., Lo, E., Manickam, K., Alfa, M., Xiao, L. & Waites, K. ( 2009; ). Ureaplasma parvum as a cause of sternal wound infection. J Clin Microbiol 47, 1976–1978.[CrossRef]
    [Google Scholar]
14. Wilcox, M. H. ( 2009; ). The tide of antimicrobial resistance and selection. Int J Antimicrob Agents 34, S6–S10.
    [Google Scholar]
15. Xie, X. & Zhang, J. ( 2006; ). Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients. FEMS Microbiol Lett 259, 181–186.[CrossRef]
    [Google Scholar]